Curnex
Product Images NDC 83335-003

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Curnex (NDC 83335-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wittman Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Curanex Label (Curanex Label)

Drug Facts panel for CurNEX Guaifenesin 400 mg Immediate Release tablets includes active ingredient guaifenesin as expectorant. It states use for thinning bronchial secretions, warnings about chronic cough and pregnancy, dosage directions limiting to 6 doses in 24 hours for those 12 years and older, storage instructions, and lists inactive ingredients. Manufactured by Wittman Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.